#ESMOGynae26
LightNews LightNews
vhio.bsky.social
👏 Congratulations to Irene Giannubilo and Carmen García Durán, oncologists from #VHIO’s Gynecological Malignancies Group‼️

Their study on HER2 expression in gynecologic tumors has been selected for poster presentation at #ESMOGynae26 and awarded an #ESMOMeritAward 🏆
@myesmo.bsky.social
June 20, 2026 at 12:03 PM
myesmo.bsky.social
📣 #ESMOGynae26: Join international experts as they explore the latest scientific and clinical advances shaping gynaecological oncology. Be the first to explore what’s coming - programme now online!

🔗 https://ow.ly/EmVK50XAuJW
December 2, 2025 at 10:55 AM
myesmo.bsky.social
📣 #ESMOGynae26: A comprehensive scientific and educational programme designed to support clinicians and researchers in delivering optimal care for patients. Abstract submission system now open!
⏰Deadline 31 March 2026
🔗 https://ow.ly/QNBR50XWGx3
#esmomeetings
January 16, 2026 at 7:45 AM
myesmo.bsky.social
📣 #ESMOGynae26: last days to register with reduced fees! Join us in Copenhagen at an event where breakthroughs are revealed. Don’t miss your chance to be in the room where new data shapes the future of gynaecological cancer care. Register by 20 May & save
🔗 https://ow.ly/qfgU50YXu14

#esmomeetings
May 12, 2026 at 5:30 AM
myesmo.bsky.social
📣 Last call for early registration savings! Engage with renowned experts sharing their insights, cutting-edge research and best practices in gynaecological oncology at #ESMOGynae26.

🔗 https://ow.ly/G70n50YGkJa

#esmomeetings
April 13, 2026 at 1:01 PM
myesmo.bsky.social
#ESMOGynae26: Data from two #ClinicalTrials provide long-term #EfficacyAndSafety evidence for the #CheckpointInhibitor dostarlimab, suggesting that immunotherapy may be used with curative intent in #EndometrialCancer. #ESMODailyReporter➡️ https://ow.ly/Mqq150ZefWk
June 18, 2026 at 2:45 PM
myesmo.bsky.social
📣 #ESMOGynae26: From laboratory discovery to clinical application, we invite you to contribute to a programme built around scientific excellence and clinical impact.
⏰ Share your research by 31 March 2026

🔗 https://ow.ly/bAAX50YrNnv
#esmomeetings
March 11, 2026 at 8:00 AM
myesmo.bsky.social
📣 #ESMOGynae26: last days to register! Join a global network of experts exploring the latest advances in diagnosis, biology and therapy in gynaecological cancers.

Register TODAY!
🔗 https://ow.ly/BNkg50Z68pa

#esmomeetings
June 10, 2026 at 6:00 AM
myesmo.bsky.social
📣 #ESMOGynae26: We invite clinicians, researchers and oncology professionals to share their work and contribute to an international scientific programme dedicated to advancing the care of patients with gynaecological cancers.
⏰ Deadline 31 March 2026

🔗 https://ow.ly/ZhCv50YxzYN

#esmomeetings
March 24, 2026 at 2:01 PM
myesmo.bsky.social
📣 #ESMOGynae26: last chance to register at a reduced fee! Join a global network of experts driving progress in gynaecological malignancies—where collaboration leads to real change in patient care.
⏰ Late registration deadline 20 May

🔗 https://ow.ly/jcsI50Z12hj

#esmomeetings
May 19, 2026 at 5:30 AM
myesmo.bsky.social
📣#ESMOGynae26: From breakthroughs in ovarian cancer therapies to new hope for rare tumours, every session is designed to bring us closer to better outcomes, earlier diagnoses, and more personalised care
⏰Share your research by 31 March 2026
#esmomeetings
🔗 https://ow.ly/MhOS50Y9XcE
February 12, 2026 at 7:00 AM
myesmo.bsky.social
🙌 #ESMOGynae26 Welcome to the global meeting place for gynaecological cancer specialists. Discover the latest science, share real-world experience, and collaborate with international experts to shape the future of patient care.
🔗 https://ow.ly/Z3WF50Zcfg1

#esmomeetings
June 17, 2026 at 6:01 AM
springerhealthplus.com
#ESMOGynae26 starts in just over a week, on June 17th.

Are you looking for a way to elevate your presentations? Get in touch today to secure the necessary rights to streamline your licensing and permissions ahead of the meeting: esmo@springer.com
June 9, 2026 at 11:10 AM
soggous.bsky.social
On my way back to London after 2 days in Copenhagen at the ESMO Gynaecological Cancer meeting #esmogynae26 It was great to meet researchers and discuss potential future projects with @lancetobgyn-wh.bsky.social Watch this space!
ESMO Gynaecological Cancers poster
June 18, 2026 at 4:58 PM
myesmo.bsky.social
#ESMOGynae26: #LiquidBiopsy, such as circulating tumour DNA to monitor tumour-derived #Biomarkers, is a minimally invasive tool with the potential to guide therapy of gynaecological cancers, as discussed by Kosei Hasegawa. #ESMODailyReporter https://ow.ly/Hpq550ZeysZ
June 19, 2026 at 11:21 AM
myesmo.bsky.social
#ESMOGynae26: Intensification #Immunotherapy could provide an efficacy benefit in patients with locally advanced #CervicalCancer, according to data from phase 2 #ClinicalTrials of nivolumab plus ipilimumab and dostarlimab.
#ESMODailyReporter: https://ow.ly/aw1H50ZefZp
June 18, 2026 at 4:15 PM
myesmo.bsky.social
#ESMOGynae26: Early-phase #ClinicalTrials in #CervicalCancer show efficacy for a nectin-4-targeting ADC as monotherapy (recurrent/metastatic disease) or with toripalimab (metastatic disease), as discussed by Camilla Nero in the #ESMODailyReporter ➡️ https://ow.ly/NlT650ZcI2w
June 17, 2026 at 2:03 PM
myesmo.bsky.social
👏 Congratulations to the #ESMOMeritAward recipients at #ESMOGynae26.
These young researchers were recognised for the scientific merit of their abstracts.
🔗 https://ow.ly/1PGm50Zc9gz
June 17, 2026 at 12:02 PM
myesmo.bsky.social
#ESMOGynae26: ADCs are transforming the treatment of advanced #OvarianCancer, #CervicalCancer and #EndometrialCancer, but what is their optimal sequencing alongside current therapies? Read Paolo Tarantino, MD's editorial in the #ESMODailyReporter 🔗 https://ow.ly/LeB450ZcASZ
June 17, 2026 at 8:15 AM
myesmo.bsky.social
📣 #ESMOGynae26 is almost here – and so is the deadline for reduced registration. Join global peers in Copenhagen to discover the latest research, connect with leading voices and engage in high-level exchange across disciplines. ⏰Reduced fees by 20 May.

🔗 https://ow.ly/6AQo50YQUil

#esmomeetings
May 4, 2026 at 9:01 AM
myesmo.bsky.social
📣 Last call! Abstract submission for #ESMOGynae26 closes soon. From bench to bedside, your research belongs on this global stage.
⏰ Deadline 31 March 2026

#esmomeetings

🔗 https://ow.ly/fHu750YzICr
March 30, 2026 at 6:00 AM
eclinicalmed.bsky.social
📢Check out our latest #News feature on the #ESMO Gynaecological Cancers Congress 2026 to read about some of the highlights from this year's event and learn more on the latest research and developments in #GynaecologicalCancers:

www.thelancet.com/journals/ecl...

#ESMOGynae26 #ESMOGynae
ESMO gynaecological cancers congress 2026
The European Society for Medical Oncology (ESMO) Gynaecological Cancers Congress 2026 took place on June 17–19 in Copenhagen, Denmark, and online. Bringing together more than 1270 delegates from 70+ c...
www.thelancet.com
July 7, 2026 at 9:10 AM